Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1glp-1thrombocytopeniapharmacovigilancesafety

SONAR Report Links GLP-1 Receptor Agonists to Severe Thrombocytopenia

Pharmacovigilance researchers describe cases of severe low platelet counts associated with GLP-1 receptor agonist therapy in Diabetes, Obesity & Metabolism.

MH
By Maren Holt · Senior Reporter, GLP-1
Sep 15 20:00 ETSource: Diabetes, obesity & metabolism

The wire

  1. 01A SONAR pharmacovigilance report describes severe thrombocytopenia associated with GLP-1 receptor agonists.
  2. 02Adds a rare but serious potential safety signal for a widely prescribed drug class.
  3. 03Case counts, causality and incidence are not established in the available excerpt.

From the source

Severe Thrombocytopenia Associated With Glucagon-Like-1 Receptor Agonists (GPL-1RA): A SONAR Report

Diabetes, obesity & metabolism · 2026 Sep 16 · Bennett CL, Nabhan C, Uslu D et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42750053/